Teva Pharma (TEVA) Launches Generic Gleevec Tablets in U.S.
August 5, 2016 8:05 AM
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of the generic equivalent to Gleevec®1(imatinib mesylate) tablets,100 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
